亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma.

医学 内科学 不利影响 胃肠病学 移植 免疫抑制 黑色素瘤 进行性疾病 彭布罗利珠单抗 癌症 疾病 免疫疗法 癌症研究
作者
Wilson H. Miller,Bertrand Routy,Rahima Jamal,D.R. Ernst,Diane E. Logan,Khashayar Esfahani,Karl Belanger,Arielle Elkrief,Réjean Lapointe,Pamela Thebault,Mayra Ponce,Seema Nair Parvathy,Meriem Messaoudene,Micheal A Silverman,Saman Maleki,John Lenehan
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:40 (16_suppl): 9533-9533 被引量:3
标识
DOI:10.1200/jco.2022.40.16_suppl.9533
摘要

9533 Background: The gut microbiome has been shown to be a biomarker of response in patients (pts) with melanoma. Strategies to modify the microbiome are currently being investigated. We report the effects of Fecal Microbiota Transplantation (FMT) on safety and anti-PD-1 response in pts with melanoma from a phase I trial (NCT03772899). Methods: 20 pts with advanced melanoma with RECIST-evaluable disease, without prior anti-PD-1 treatment for advanced disease, were recruited from 3 Canadian academic centers. Pts with ECOG > 2, autoimmune diseases, immunosuppression or unstable brain metastases were excluded. Pts received 80-100 g of healthy donor stool via oral capsules and were treated with anti-PD-1 one week later. The primary objective was safety of combining FMT with anti-PD-1 therapy. Objective response rate (ORR) by RECIST 1.1 and correlative studies were secondary objectives. Flow cytometry and multiplex ELISA were performed on pts blood samples. Avatar mice were transplanted with stool samples obtained from participants on the trial before and after FMT. Mice were subsequently implanted with B-16 or MCA-205 tumors and received anti-PD-1 antibodies. Results: Median age was 75.5 years, 12 (60%) were male, 18 (90%) had stage 4 disease, and 5 (25%) pts harbored a BRAF mutation. Median follow-up was 11.2 months. FMT-related adverse events included grade 2 diarrhea (2 pts) and hypophosphatemia (1 pt), and 13 pts (65%) experienced grade 1 gastrointestinal toxicities. Grade 3 immune-related adverse events (irAE) were one each of myocarditis, nephritis, and fatigue. Anti-PD-1 therapy was discontinued for toxicity in 2 (10%) pts. No unexpected irAE or death on treatment occurred. ORR was 65% (13/20), of which 3 were CR. Clinical benefit rate (includes SD lasting > 6 months) was 75% (15/20). Median PFS was not reached, and one pt died from their disease. Translational analyses demonstrated upregulation of IL-17 post-FMT in responders, which correlated with upregulation of the frequency of Th17 cells in peripheral blood. In parallel, murine experiments showed that feces from pts pre-FMT did not sensitize tumors to anti-PD-1. In both tumor models, only feces obtained post-FMT from responders restored anti-PD-1 efficacy in mice, providing strong support that FMT contributed to the anti-tumor response observed in pts. Conclusions: FMT followed by anti-PD-1 treatment in melanoma pts undergoing therapy is safe and may lead to improved anti-tumor responses that can be reproduced in tumor mouse models. The gut microbiome plays an important role in responses to anti-PD-1 in patients with advanced melanoma, paving the way for future microbiome-based interventions. Clinical trial information: NCT03772899.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
NexusExplorer的应助被王老裂采纳,获得10
刚刚
1秒前
2秒前
风吹麦浪发布了新的文献求助10
2秒前
风吹麦浪发布了新的文献求助10
3秒前
风吹麦浪发布了新的文献求助10
3秒前
风吹麦浪发布了新的文献求助10
3秒前
风吹麦浪发布了新的文献求助10
3秒前
风吹麦浪发布了新的文献求助10
3秒前
风吹麦浪发布了新的文献求助10
4秒前
4秒前
风吹麦浪发布了新的文献求助10
4秒前
风吹麦浪发布了新的文献求助30
4秒前
风吹麦浪发布了新的文献求助10
4秒前
风吹麦浪发布了新的文献求助100
5秒前
风吹麦浪发布了新的文献求助10
5秒前
慕青的应助被Foloydon采纳,获得10
6秒前
风吹麦浪发布了新的文献求助100
7秒前
风吹麦浪发布了新的文献求助10
7秒前
风吹麦浪发布了新的文献求助150
8秒前
8秒前
风吹麦浪发布了新的文献求助10
9秒前
风吹麦浪发布了新的文献求助10
9秒前
9秒前
风吹麦浪发布了新的文献求助10
9秒前
10秒前
KeiraWoo的应助被科研通管家采纳,获得10
11秒前
研友_VZG7GZ的应助被科研通管家采纳,获得20
11秒前
11秒前
12秒前
12秒前
12秒前
13秒前
13秒前
风吹麦浪发布了新的文献求助10
13秒前
13秒前
风吹麦浪发布了新的文献求助10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158601
求助须知:如何正确求助?哪些是违规求助? 9554379
关于积分的说明 21719104
捐赠科研通 7748129
什么是DOI,文献DOI怎么找? 3427052
关于科研通互助平台的介绍 2551912
邀请新用户注册赠送积分活动 2471285